Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Visceral Pain Market Expansion Outlook: What Revenue Opportunities Lie Ahead?
The market for visceral pain interventions has experienced robust expansion recently, and this upward trajectory is projected to continue. Specifically, the market is anticipated to expand from $14.82 billion in 2025 to $15.7 billion in 2026, reflecting a compound annual growth rate of 5.9%. Factors contributing to this growth during the earlier period include a rise in gastrointestinal and pelvic health issues, heightened prescription of NSAIDs and calcium channel blockers, enhanced diagnostic awareness of visceral pain conditions, the proliferation of pain management services within healthcare facilities, and the availability of a variety of pharmacological options.
The market for visceral pain treatments is projected for substantial expansion over the coming years, reaching an estimated value of $19.6 billion by 2030, driven by a compound annual growth rate of 5.7%. This anticipated expansion is fueled by several key factors, including a heightened demand for customized therapeutic approaches to pain management, a greater emphasis on addressing chronic pain conditions, the increasing integration of precision medicine methodologies, the widespread adoption of sophisticated diagnostic technologies, and a significant surge in investments directed towards the development of non-opioid pharmaceutical solutions. Furthermore, prominent trends anticipated during this forecast period encompass a growing inclination towards specialized pain management strategies, a more frequent utilization of combined drug therapies, an escalating preference for treatment alternatives that do not involve opioids, the broadening scope of individualized visceral pain care, and a strengthened focus on detecting and intervening in pain conditions at an earlier stage.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13950&type=smp
Visceral Pain Market Growth Drivers And Industry Catalysts
The increasing consumption of pain-relieving drugs is anticipated to propel the visceral pain market forward. Analgesics are substances that offer relief from pain by either reducing or intercepting the pain signals reaching the brain. These medications effectively manage visceral pain by influencing the nervous system and altering the pain impulses generated by internal organs. As an illustration, data from the New England Journal of Medicine, a prominent UK medical publication, indicated that by December 2023, more than 53,600 healthcare professionals were prescribing buprenorphine, marking a substantial rise of 11,500 prescribers compared to the figures from December 2022, as reported in April 2024. Consequently, the escalating need for analgesics is a key factor contributing to the expansion of the visceral pain market.
Visceral Pain Market Segment Landscape And Growth Potential
The visceral pain market covered in this report is segmented –
1) By Drug Class: Calcium Channel Blockers, Nonsteroidal Anti-Inflammatory (NSAID), Other Drug Classes
2) By Indications: Interstitial Cystitis, Crohn’s, Irritable Bowel, Chronic Prostatitis, Other Indications
3) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAID): Selective COX-2 Inhibitors, Non-Selective NSAIDs
3) By Other Drug Classes: Opioids, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
#Visceral Pain Market Trends Influencing Long-Term Demand
Leading entities within the chronic pain sector are directing their efforts toward clinical investigations aimed at pioneering novel solutions, specifically NOP receptor agonists, for superior pain management that could mitigate the drawbacks linked to opioid therapies. These NOP receptor agonists function by stimulating the nociceptin/orphanin FQ peptide receptor, a mechanism that influences pain transmission in the nervous system, thereby alleviating persistent and internal discomfort without the significant dangers of dependence or adverse effects commonly linked to conventional opioids. As an illustration, Grünenthal GmbH, a pharmaceutical firm headquartered in Germany, commenced a Phase I trial involving 90 healthy individuals in October 2024 to gauge the safety, patient tolerance, and pharmacokinetic profile of their new NOP receptor agonist. The objective of this research is to determine the investigational substance’s capacity for effective and secure pain reduction in various chronic pain states, presenting a new therapeutic avenue for addressing both bodily and visceral pain.
Visceral Pain Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the visceral pain market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co.Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Endo International PLC, Grünenthal GmbH, Glenmark Pharmaceuticals Limited, Hisamitsu Pharmaceutical Co. Ltd., Chromocell Corporation, Addex Therapeutics Ltd.
Access The Complete Visceral Pain Market Report:
https://www.thebusinessresearchcompany.com/report/visceral-pain-global-market-report
Visceral Pain Market Leading Geography: Which Region Generates The Most Revenue?
North Americawas the largest region in the visceral pain market in 2025. The regions covered in the visceral pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
